Drug class
Angiotensin II Type 1 Receptor Blockers clinical trials
A class of medicines: the studies that test any of its 7 members, each study once. Members are as MeSH files each medicine’s actions, and as the NCI Thesaurus classes newer ones.
Keep track of what changes. Save the angiotensin ii type 1 receptor blockers studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesMedicines in this class
Studies that test each. A study of two counts under both, and once above.
Studies by the year they started
894 studies that test it; most in 2007 (70); 1 more planned to start later
| Year | Studies |
|---|---|
| 1990 | 1 |
| 1991 | 2 |
| 1992 | 1 |
| 1995 | 2 |
| 1997 | 4 |
| 1998 | 10 |
| 1999 | 9 |
| 2000 | 10 |
| 2001 | 13 |
| 2002 | 25 |
| 2003 | 31 |
| 2004 | 50 |
| 2005 | 61 |
| 2006 | 65 |
| 2007 | 70 |
| 2008 | 43 |
| 2009 | 50 |
| 2010 | 31 |
| 2011 | 28 |
| 2012 | 27 |
| 2013 | 34 |
| 2014 | 43 |
| 2015 | 28 |
| 2016 | 20 |
| 2017 | 20 |
| 2018 | 31 |
| 2019 | 24 |
| 2020 | 41 |
| 2021 | 25 |
| 2022 | 21 |
| 2023 | 21 |
| 2024 | 20 |
| 2025 | 15 |
| 2026 | 18 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
- Hypertension
- 288
- COVID-19
- 18
Who runs them
Industry 439 · Other 470
Novartis (73) · Boehringer Ingelheim (71) · Novartis Pharmaceuticals (29) · Takeda (26) · Sanofi (24) · Chong Kun Dang Pharmaceutical (21) · Daiichi Sankyo (19) · AstraZeneca (17)
Studies
Open first, then newest update. How each study uses a medicine is read from its arms, and is right about nine times in ten.
Testing one of them · 909
- Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)Enrolling by invitationPhase 4Baylor Research InstituteNCT07547878Written as Edarbi
- Losartan and Paclitaxel in Platinum Resistant Ovarian CancerNot yet recruitingPhase 2Massachusetts General HospitalNCT07265739Written as losartan
- Manganese-enhanced Magnetic Resonance Imaging in Takotsubo CardiomyopathyRecruitingNot applicableUniversity of EdinburghNCT07491718Written as Valsartan
- A Study of Angiotensin-II Receptor Blocker on Cardiovascular Remodeling (VALUE Trial)RecruitingPhase 3Mayo ClinicNCT06150560Written as Losartan
- A Phase 1 Clinical Trial to Evaluate the Safety and the Pharmacokinetic Drug-Drug Interaction Between HUC2A-752-A and HUC2A-752-B in Healthy AdultsNot yet recruitingPhase 1Huons Co., Ltd.NCT07784621Written as Losartan (COZZAR®)
- A Clinical Trial to Evaluate the Drug-drug Interactions of Co-administered 'HUC2-744-A' and 'HUC2-744-B' in Healthy Adult VolunteersNot yet recruitingPhase 1Huons Co., Ltd.NCT07784608Written as Telmisartan
- Losartan + Sunitinib in Treatment of OsteosarcomaRecruitingPhase 1University of Colorado, DenverNCT03900793Written as Losartan
- Effects of VALsartan On atRIAl Mitral Regurgitation (VALORIA) - PilotRecruitingPhase 2/3Jonathan BeaudoinNCT07539298Written as Valsartan
- Secondhand Tobacco Smoke and Cardiovascular DiseaseRecruitingPhase 4University of California, San FranciscoNCT04715568Written as Losartan
- The Effect of Sacubitril/Valsartan Versus Ramipril on Left Ventricular Function and Remodeling in Patients With Ischemic Heart Failure With Mid-range Ejection FractionRecruitingPhase 3John Paul II Hospital, KrakowNCT05508035Written as Sacubitril / Valsartan
- Relying on Pharmacotherapy to Improve Motor Gains in Chronic Stroke SurvivorsRecruitingEarly Phase 1Spaulding Rehabilitation HospitalNCT07588932Written as Telmisartan, Metformin, Cilostazol
- TriGlytza®-01 Versus Metformin in Overweight and Obese Adults With Type 2 Diabetes and Inadequate Glycaemic Control Despite Metformin TherapyNot yet recruitingPhase 2Myopharm LimitedNCT07139405Written as Valsartan
- Treating Heart Dysfunction Related to Cancer Therapy With Sacubitril/ValsartanRecruitingPhase 1/2Virginia Commonwealth UniversityNCT05194111Written as Valsartan
- Comparative Effectiveness of Dual Antihypertensive Regimens in Patients After Percutaneous Coronary InterventionRecruitingNot applicableNational Medical Research Center for Therapy and Preventive MedicineNCT07683585Written as Losartan + Hydrochlorothiazide
- Sacubitril-valsartan in Patients With Heart Failure With Reduced Ejection Fraction From Rural TanzaniaRecruitingPhase 4Martin RohacekNCT06704633Written as Sacubitril / Valsartan Oral Tablet
- Role of Sympathetic Overactivity and Angiotensin II in PTSD and CVRecruitingPhase 2Emory UniversityNCT02560805Written as Losartan
- Losartan for Corneal FibrosisRecruitingNot applicableUniversidad Autonoma de Nuevo LeonNCT07449000Written as Topical losartan
- Impact of Medically Supervised Performance-Enhancing Substances (PES) on Elite AthletesEnrolling by invitationNot applicableEnhanced Emirates LimitedNCT07568574Written as Telmisartan
- Repurposing Valsartan May Protect Against Pulmonary HypertensionRecruitingPhase 2University of WashingtonNCT06053580Written as Valsartan 40 mg
- Investigation of the Effectiveness of Exercise and Anti-Fibrotic Approaches in Frozen ShoulderRecruitingNot applicableIstanbul UniversityNCT07513350Written as Losartan
See all 909 studies that test one of the angiotensin ii type 1 receptor blockers →
Codes
What other systems call Angiotensin II Type 1 Receptor Blockers · ClinicalTrials.gg INT008851
- MeSH (NLM) D047228Angiotensin II Type 1 Receptor BlockersOne source ClinicalTrials.gov
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D047228 | Angiotensin II Type 1 Receptor Blockers | One source ClinicalTrials.gov |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.